About Event
The Only Industry Meeting Place for CAR & TCR Cell Therapy Development
As cell therapies continue to demonstrate transformative potential in the clinic whilst reaching new milestones for commercial success, the 10th CAR-TCR Summit is returning as the world’s leading global forum to accelerate end-to-end development of cell therapies to patients in need.
Built by industry for industry, this year’s agenda features end-to-end coverage of every stage of cell therapy development. From breakthroughs in novel engineering and armoring technologies, streamlined manufacturing to meet tight timelines, optimizing pre-clinical models to reviewing clinical data, to efficiently characterizing your cell therapy product.
Whether you’re a C-level strategic leader, or analytical scientist, you’re guaranteed to leave with actionable solutions to combat the challenges currently halting your therapeutic development and effectively translate your cell therapy from bench to bedside.
The cell therapy community is stronger together. Seize your opportunity to come together this September in an industry-focused environment to celebrate a decade of engineering a disease-free world, and solidify your impact on the future of cell therapy development in pursuit of the shared mission of bringing more life-saving therapies to patients in need.
Why is This Meeting a Must-Attend?
This is the blueprint industry meeting for cell therapy developers. Uniting academic KOLs, biopharma decision makers, pharma partnering leads, front-line scientists, and leading service providers to collaboratively address shared challenges and celebrate advances
You'll hear brand new clinical data from Capstan Therapeutics, Legend Biotech and MiNK Therapeutics showcasing their ground-breaking work in in vivo CAR-T, solid tumors targeting with CAR-T and the success of cell therapies beyond oncology
You will gain competitive insight across multiple scopes of indications from oncology to autoimmune to cover the growing trial expansion and ensure you stay ahead of the curve
It's more than just CAR & TCR content… this meeting will cover the full range of cell types, including NK cells, Gamma Delta cells, Macrophages, TILs, and more to provide holistic coverage of cutting-edge scientific advancement in cell therapy
Cutting-Edge Scientific Content Catering to all Stages of Development:
Discovery:
Innovate the next generation of cell therapy development to broaden the scope of target indications.
Meet CSOs, CEOs, Pre-clinical Development Scientists, Heads, VPs and Directors of Research and Biology
Translational:
Optimize translational development to gain regulatory approval.
Meet Global Heads and Presidents working on translational, pharmacology and biomarker development, and Global Heads of immunology and translational biology
Clinical Development
Demonstrate, safety, efficacy and durability across multiple cell types and indications to ensure clinical success.
Meet VPs and Heads of Clinical Development, Clinical Trial Leads and Heads of Regulatory Development
Early-Stage Manufacturing
Optimize process development and validation to establish robust platforms.
Meet CTOs, Heads of Process Development and Scientists focused on pre-clinical and early clinical manufacturing
Late-Stage Manufacturing
Master manufacturing process and overcome high costs to streamline manufacturing.
Meet CTOs, Global Heads of Manufacturing and MSAT Scientists
Analytical Development
Develop robust assays, optimize quality control and master varying instruments.
Meet VPs of Quality Control, Heads of Assay Developments and Scientists focusing on Analytical Development
Meet & Network with Experts from the Full Cell Therapy Landscape
“I’m looking forward to hearing from other biotech companies the progress that has been made over the past year on various fronts from research to manufacturing to clinical and beyond.”
Legend Biotech, 2025 Speaker
Connect With Us to Stay Up to Date with the Field!
Join Our Twitter Following:
Join the LinkedIn Community:
